StockData
Dr Reddys Laboratories Ltd logo

Dr Reddys Laboratories Ltd (RDY) stock

RDYNYSEPharmaceutical PreparationsFiscal year ends March 31
Số liệu tài chính tới năm tài chính 2026, năm kết thúc ngày Mar 31, 2026Score 7/30
$14.98+0.19 (+1.28%)

Close on Nov 18, 2026Market cap $12.50BP/E 27.5Yield 0.57%

Dr Reddys Laboratories pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Dr Reddys Laboratories's pe ratio was 27.1× on Nov 11, 2026, against 18.5× a year earlier. Over the last 5 years it ranged from 16.7× to 46.9×, with a median of 21.4×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202627.1×+8.5
2025Dec 31, 202518.6×−1.6
2024Dec 31, 202420.2×−1.1
2023Dec 29, 202321.4×−8.8
2022Dec 30, 202230.2×−16.7
2021Dec 31, 202146.9×+2.6
2020Dec 31, 202044.3×+18.7
2019Dec 31, 201925.6×−18.9
2018Dec 31, 201844.5×+11.2
2017Dec 29, 201733.3×+7.0
2016Dec 30, 201626.3×–

More Dr Reddys Laboratories figures

See a number that looks wrong?